Literature DB >> 16785347

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Larry B Goldstein, Robert Adams, Mark J Alberts, Lawrence J Appel, Lawrence M Brass, Cheryl D Bushnell, Antonio Culebras, Thomas J DeGraba, Philip B Gorelick, John R Guyton, Robert G Hart, George Howard, Margaret Kelly-Hayes, J V Ian Nixon, Ralph L Sacco.   

Abstract

BACKGROUND AND
PURPOSE: This guideline provides an overview of the evidence on various established and potential stroke risk factors and provides recommendations for the reduction of stroke risk.
METHODS: Writing group members were nominated by the committee chair on the basis of each writer's previous work in relevant topic areas and were approved by the American Heart Association Stroke Council's Scientific Statement Oversight Committee. The writers used systematic literature reviews (covering the time period since the last review published in 2001 up to January 2005), reference to previously published guidelines, personal files, and expert opinion to summarize existing evidence, indicate gaps in current knowledge, and when appropriate, formulate recommendations based on standard American Heart Association criteria. All members of the writing group had numerous opportunities to comment in writing on the recommendations and approved the final version of this document. The guideline underwent extensive peer review before consideration and approval by the AHA Science Advisory and Coordinating Committee.
RESULTS: Schemes for assessing a person's risk of a first stroke were evaluated. Risk factors or risk markers for a first stroke were classified according to their potential for modification (nonmodifiable, modifiable, or potentially modifiable) and strength of evidence (well documented or less well documented). Nonmodifiable risk factors include age, sex, low birth weight, race/ethnicity, and genetic factors. Well-documented and modifiable risk factors include hypertension, exposure to cigarette smoke, diabetes, atrial fibrillation and certain other cardiac conditions, dyslipidemia, carotid artery stenosis, sickle cell disease, postmenopausal hormone therapy, poor diet, physical inactivity, and obesity and body fat distribution. Less well-documented or potentially modifiable risk factors include the metabolic syndrome, alcohol abuse, drug abuse, oral contraceptive use, sleep-disordered breathing, migraine headache, hyperhomocysteinemia, elevated lipoprotein(a), elevated lipoprotein-associated phospholipase, hypercoagulability, inflammation, and infection. Data on the use of aspirin for primary stroke prevention are reviewed.
CONCLUSIONS: Extensive evidence is available identifying a variety of specific factors that increase the risk of a first stroke and providing strategies for reducing that risk.

Entities:  

Mesh:

Year:  2006        PMID: 16785347     DOI: 10.1161/01.STR.0000223048.70103.F1

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  102 in total

1.  Periodontal bacteria and hypertension: the oral infections and vascular disease epidemiology study (INVEST).

Authors:  Moïse Desvarieux; Ryan T Demmer; David R Jacobs; Tatjana Rundek; Bernadette Boden-Albala; Ralph L Sacco; Panos N Papapanou
Journal:  J Hypertens       Date:  2010-07       Impact factor: 4.844

2.  The health implications of sucrose, high-fructose corn syrup, and fructose: what do we really know?

Authors:  James M Rippe
Journal:  J Diabetes Sci Technol       Date:  2010-07-01

3.  Fitness and Mobility Exercise (FAME) Program for stroke.

Authors:  Janice J Eng
Journal:  Top Geriatr Rehabil       Date:  2010

4.  Use of antithrombotic medications among elderly ischemic stroke patients.

Authors:  Judith H Lichtman; Lisa Naert; Norrina B Allen; Emi Watanabe; Sara B Jones; Lisa C Barry; Dawn M Bravata; Larry B Goldstein
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-11-23

5.  A narrative review of pathophysiological mechanisms associated with cervical artery dissection.

Authors:  Michael Haneline; Gary N Lewkovich
Journal:  J Can Chiropr Assoc       Date:  2007

6.  The Pro12Ala polymorphism in PPARG2 increases the effectiveness of primary prevention of cardiovascular disease by a lifestyle intervention.

Authors:  K Rittig; C Thamer; F Machicao; R Rietig; N Stefan; A Fritsche; H-U Haring; B Balletshofer
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122

7.  Reduction in incident stroke risk with vigorous physical activity: evidence from 7.7-year follow-up of the national runners' health study.

Authors:  Paul T Williams
Journal:  Stroke       Date:  2009-03-19       Impact factor: 7.914

8.  Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats.

Authors:  Zhenjun Tan; Xinlan Li; Ryan C Turner; Aric F Logsdon; Brandon Lucke-Wold; Kenneth DiPasquale; Soon Soeg Jeong; Ridong Chen; Jason D Huber; Charles L Rosen
Journal:  Eur J Pharmacol       Date:  2014-06-13       Impact factor: 4.432

Review 9.  Antihypertensive treatment and stroke prevention: from recent meta-analyses to the PRoFESS trial.

Authors:  Guido Grassi; Fosca Quarti-Trevano; Raffaella Dell'oro; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

10.  Carotid MR angiography with traditional bolus timing: clinical observations and Fourier-based modelling of contrast kinetics.

Authors:  Jan Menke
Journal:  Eur Radiol       Date:  2009-05-16       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.